KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-Current Deffered Revenue (2016 - 2017)

Supernus Pharmaceuticals has reported Non-Current Deffered Revenue over the past 7 years, most recently at $1.1 million for Q4 2017.

  • Quarterly Non-Current Deffered Revenue fell 23.45% to $1.1 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2017, down 23.45% year-over-year, with the annual reading at $1.1 million for FY2017, 23.45% down from the prior year.
  • Non-Current Deffered Revenue was $1.1 million for Q4 2017 at Supernus Pharmaceuticals, down from $1.2 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $1.7 million in Q1 2016 and troughed at $738000.0 in Q2 2013.
  • The 5-year median for Non-Current Deffered Revenue is $1.3 million (2014), against an average of $1.3 million.
  • Year-over-year, Non-Current Deffered Revenue skyrocketed 358.58% in 2013 and then dropped 23.45% in 2017.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $1.4 million in 2013, then fell by 10.09% to $1.3 million in 2014, then grew by 9.11% to $1.4 million in 2015, then grew by 7.99% to $1.5 million in 2016, then dropped by 23.45% to $1.1 million in 2017.
  • Per Business Quant, the three most recent readings for SUPN's Non-Current Deffered Revenue are $1.1 million (Q4 2017), $1.2 million (Q3 2017), and $1.3 million (Q2 2017).